Some retinal diseases require precise delivery of medication directly into the eye rather than general treatment. In such cases, intravitreal injections are used—a modern method in which medication is injected directly into the vitreous. At the K+31 clinic, we follow current protocols, use modern medications, and thoroughly explain each step of therapy to patients. It's important for us not only to perform the procedure but also to provide a clear treatment plan, vision monitoring, and post-injection follow-up.
Not all patients require this therapy. The decision on treatment is made only by an ophthalmologist after examination and assessment of the retina.
Intravitreal injections are most often prescribed for conditions associated with retinal vascular damage and fluid accumulation in the macula.
Main indications include:
In some cases, therapy is administered in a course. The frequency of administration depends on the diagnosis and the ocular tissue response to the drug.
There are situations in which treatment is temporarily postponed. For example, in cases of severe eye inflammation, infectious diseases, or the patient's unstable general condition.
The doctor also evaluates the presence of contraindications and possible risks. It is not recommended to independently choose a medication or try to change the therapy.
Before starting therapy, we perform a retinal examination and assess the condition of the macula. We use modern equipment, including OCT (optical coherence tomography).
This examination helps determine the cause of vision loss, assess the thickness of the retina, and understand the activity of the disease.
“We always select an intravitreal drug after a diagnosis and explain each step to the patient. Our goal is not just to administer an injection, but to ensure a clear treatment plan, monitoring of results, and safety at every step.”
For many patients, the main fear is associated with the injection itself. Therefore, we explain in detail how the procedure works, what sensations are considered normal, and why the treatment is only performed in a medical setting.
Before the procedure, an examination and re-evaluation of the eye's condition are performed. The doctor clarifies any complaints, reviews the examination results, and rules out any contraindications.
We work exclusively in sterile conditions. Operating rooms are disinfected in accordance with international protocols. Antiseptic solutions and local anesthetic drops are used before injections.
During the procedure, an injection is administered into the vitreous through a small access point. The intravitreal injection itself takes only a short time.
The patient is in a comfortable position, and the doctor monitors all stages of the procedure. After the solution is administered, the eye is examined and monitored.
All procedures are performed in a sterile room, following current protocols and clinical guidelines.
Due to the use of local anesthesia, there is usually no significant pain. The patient may feel pressure, mild discomfort, or a brief foreign body sensation.
After the procedure, eye redness, tearing, or irritation may sometimes occur. These symptoms usually subside gradually.
This award is given to clinics with the highest ratings according to user ratings, a large number of requests from this site, and in the absence of critical violations.
This award is given to clinics with the highest ratings according to user ratings. It means that the place is known, loved, and definitely worth visiting.
The ProDoctors portal collected 500 thousand reviews, compiled a rating of doctors based on them and awarded the best. We are proud that our doctors are among those awarded.
Экстренная помощь
What is intravitreal injection and how does it work?
Intravitreal drug administration is an injection into the vitreous body of the eye. This approach helps deliver the drug precisely to the affected area and create the necessary concentration of the substance near the retina and macula.
This method is actively used in modern ophthalmology for diseases associated with retinal vascular damage, macular edema, and impaired ocular tissue nutrition. Unlike systemic therapy, the drug acts locally and has virtually no significant impact on the entire body.
How the procedure works
After administration, the drug begins to work directly inside the eye. This is especially important for diseases that affect the retina and the central area of vision—the macula.
Some pathologies cause abnormal blood vessels to form in the eye or macular edema to develop. This leads to impaired tissue nutrition and decreased vision. In such cases, anti-VEGF therapy is used to help control the growth of abnormal vessels and reduce swelling.
Treatment is individualized. The doctor evaluates the examination results, the stage of the disease, and the eye tissue's response to treatment.
What medications are used?
Different groups of medications are used for treatment. Most commonly, anti-VEGF therapy is used, as well as anti-inflammatory injections.
The choice depends on the diagnosis. For wet AMD and vascular disorders, the treatment goal is different for inflammatory diseases. This is why intravitreal drug administration in Moscow should always be performed after diagnosis and specialist examination.
We always explain to the patient why a specific medication has been chosen and what results can be expected from the therapy.
For what conditions is it prescribed?
The main goal of the procedure is to treat retinal diseases that require local action on the eye tissue.
Indications for intravitreal drug administration:
The procedure is also used for conditions such as retinal vein thrombosis, chronic macular edema, and some complications of diabetes.